Although germline variants in BRCA1, BRCA2 and other HR repair (HRR) pathway genes have been described in large sequencing studies of pediatric oncology patients7,14, the relevance of these findings to pediatric cancer pathogenesis remains unclear. This evidence concerns the gene BRCA1 and cancer.